The Humanized Mouse Model Market is being driven by Growing adoption of personalized medicine
The Humanized Mouse Model Market is expected to grow at a CAGR of 6.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 61.6 million. Companies in the global humanized mouse model market are implementing strategic initiatives to maintain their market dominance. These strategies include forming partnerships to enhance product offerings and broaden customer reach through new distribution channels. Notable collaborations in this sector include Heligenics, Inc.'s licensing agreement with The Jackson Laboratory (JAX) in May 2023, granting JAX access to Heligenics' ERBB2 gene mutation library. Additionally, The Children's Cancer Therapy Development Institute, Champions Oncology, and JAX have joined forces to offer RACEact/PREA pediatric cancer study plan services.
Get more information on Humanized Mouse Model Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
214 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.7% |
Market growth 2025-2029 |
USD 61.6 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
6.5 |
Key countries |
US, China, Germany, France, Canada, UK, Japan, Brazil, India, South Korea, US, Canada, India, Japan, Australia, South Korea, China, UK, Germany, South Africa, Saudi Arabia, Malaysia, and Hong Kong |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The humanized mouse model market encompasses various models such as liver, lung, brain, tumor, microbiome, and skin, which are engineered to mimic the human immune system for improved research in areas like immune system reconstitution, complement-dependent cytotoxicity, and testing of immune checkpoint inhibitors, car T-cell therapy, and personalized immunotherapy. These models facilitate studies on the tumor microenvironment, drug resistance, target validation, and toxicology, enabling pharmacokinetic, pharmacodynamic, safety assessment, efficacy studies, clinical trial design, patient recruitment, data management, biostatistical analysis, regulatory affairs, and intellectual property protection.
The life science tools and services market encompasses companies and offerings involved in the research and development (R&D) of a diverse range of products and services. These include capital equipment, instruments, accessories, and consumables utilized in the production of pharmaceuticals, biotechnology products, and laboratory diagnostics. Additionally, life sciences-related services such as contract research, manufacturing, and sales are included in this market. According to Technavio, the expansion of the global healthcare market is primarily driven by the increasing elderly population, leading to a heightened demand for advanced medical research. Humanized mouse models, such as knockout mice, transgenic mice, immunocompromised mice, and those with humanized immune systems, as well as human cell lines and xenograft models, are essential tools in this market. These models facilitate the study of human diseases and the development of targeted therapies, contributing significantly to the growth of the market.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted